Skip to Content
  • Previous Rank
  • Revenues ($M)
  • Revenue Percent Change
  • Profits ($M)
  • Profits Percent Change
  • Assets ($M)
  • Employees
  • Market Value — as of March 29, 2018 ($M)

A distributor of pharmaceutical and medical products, Cardinal climbed one spot on this year’s 500 thanks to a 7% jump in sales. While business was brisk, weak pricing of generic drugs and the loss of a contract with Safeway led to a 10% loss in profits in 2017. Like its competitors, Cardinal has come under fire–and faces a bevy of lawsuits–for its alleged role in the nation’s opioid epidemic.

41319CFF-E47E-4BA5-B1B8-ECA4D480B0DFCreated with sketchtool.62900797-6A09-46DF-8323-A45758A81292Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

Company Info

Michael C. Kaufmann
CEO Title
Chairman & Chief Executive Officer
Wholesalers: Health Care
HQ Location
Dublin, Ohio
Years on Fortune 500 List24
Figures are for fiscal year ended June 30, 2017.

Cardinal Health Rank History


Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$129,976.006.9%
Profits ($M)$1,288.00-9.7%
Assets ($M)$40,112.00-
Total Stockholder Equity ($M)$6,808.00-
Market Value — as of March 29, 2018 ($M)$19,725.80-

Profit Ratios

Profit as % of Revenues1%
Profits as % of Assets3.2%
Profits as % of Stockholder Equity18.9%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)4.03
EPS % Change (from 2016)-6.7%
EPS % Change (5 year annual rate)5.7%
EPS % Change (10 year annual rate)-1.7%

Total Return

Total Return to Investors (2017)-12.8%
Total Return to Investors (5 year, annualized)10.6%
Total Return to Investors (10 year, annualized)6%